New Market Report: Neurofibromatoses Type II - Pipeline Review, H1 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neurofibromatoses Type II - Pipeline Review, H1 2017, provides an overview of the Neurofibromatoses Type II (Genetic Disorders) pipeline landscape.
View full press release